Literature DB >> 29191408

The retrieval of at least 25 lymph nodes should be essential for advanced gastric cancer patients with lymph node metastasis: A retrospective analysis of single-institution database study design: Cohort study.

Bochao Zhao1, Jiale Zhang1, Xiuxiu Chen1, Tianmin Sun1, Zhenning Wang1, Huimian Xu1, Baojun Huang2.   

Abstract

BACKGROUND: Recently, increased evidence have shown that the better prognosis of gastric cancer (GC) patients was associated with the larger number of retrieved lymph nodes (RLNs), but the optimal number of RLNs remains controversial. In the present study, we investigated whether adequate LN retrieval (≥15) was necessary to evaluate the prognosis of patients and attempted to propose an appropriate cutoff-point for the number of RLNs.
METHODS: We reviewed 2246 GC patients who underwent radical gastrectomy in our research institution between January 1986 and January 2008. All patients were divided into several groups based on the number of RLNs. The prognostic outcomes of different patient groups were compared and clinicopathologic features were analyzed.
RESULTS: In the present study, our results indicated that ≥15 RLNs showed a better survival outcome than inadequate LN retrieval (<15), regardless of the node-negative or node-positive GC patients (P < 0.001). For the more advanced GC patients (T2-T4 stage, N1-N3 stage, and stage II-stage III), the retrieval of 25-29 LNs could provide a better survival benefit compared with <25 or ≥30 RLNs (P < 0.05). In addition, for the patients who underwent proximal or total gastrectomy, the superior prognosis was still observed in the patient group with 25-29 RLNs.
CONCLUSION: The minimal goal of 15 RLNs may not be enough to accurately evaluate prognosis of all patients and at least 25 RLNs should be necessary for advanced GC patients with lymph node metastasis.
Copyright © 2017. Published by Elsevier Ltd.

Entities:  

Keywords:  Gastric cancer; Lymph node dissection; Lymph node retrieval; Staging; Survival

Mesh:

Year:  2017        PMID: 29191408     DOI: 10.1016/j.ijsu.2017.11.036

Source DB:  PubMed          Journal:  Int J Surg        ISSN: 1743-9159            Impact factor:   6.071


  5 in total

1.  Impact of Laparoscopic Converted to Open Gastrectomy on Short- and Long-Term Outcomes of Patients with Locally Advanced Gastric Cancer: A Propensity Score-Matched Analysis.

Authors:  Feng-Ni Xie; Jie Chen; Zheng-Yan Li; Bin Bai; Dan Song; Shuai Xu; Xiao-Tian Song; Gang Ji
Journal:  J Gastrointest Surg       Date:  2021-04-05       Impact factor: 3.452

2.  Number of retrieved lymph nodes is an independent prognostic factor after total gastrectomy for patients with stage III gastric cancer: propensity score matching analysis of a multi-institution dataset.

Authors:  Shogo Hayashi; Mitsuro Kanda; Seiji Ito; Yoshinari Mochizuki; Hitoshi Teramoto; Kiyoshi Ishigure; Toshifumi Murai; Takahiro Asada; Akiharu Ishiyama; Hidenobu Matsushita; Chie Tanaka; Daisuke Kobayashi; Michitaka Fujiwara; Kenta Murotani; Yasuhiro Kodera
Journal:  Gastric Cancer       Date:  2018-11-27       Impact factor: 7.370

3.  Retrieved lymph nodes from different anatomic groups in gastric cancer: a proposed optimal number, comparison with other nodal classification strategies and its impact on prognosis.

Authors:  Siwei Pan; Pengliang Wang; Yanan Xing; Kai Li; Zhenning Wang; Huimian Xu; Zhi Zhu
Journal:  Cancer Commun (Lond)       Date:  2019-09-13

4.  Impact of examined lymph node count on staging and long-term survival of patients with node-negative stage III gastric cancer: a retrospective study using a Chinese multi-institutional registry with Surveillance, Epidemiology, and End Results (SEER) data validation.

Authors:  Nannan Zhang; Huihui Bai; Jingyu Deng; Wei Wang; Zhe Sun; Zhenning Wang; Huimian Xu; Zhiwei Zhou; Han Liang
Journal:  Ann Transl Med       Date:  2020-09

5.  Short-term surgical outcomes of laparoscopy-assisted versus open D2 distal gastrectomy for locally advanced gastric cancer in North China: a multicenter randomized controlled trial.

Authors:  Zaozao Wang; Jiadi Xing; Jun Cai; Zhongtao Zhang; Fei Li; Nengwei Zhang; Jixiang Wu; Ming Cui; Ying Liu; Lei Chen; Hong Yang; Zhi Zheng; Xiaohui Wang; Chongchong Gao; Zhe Wang; Qing Fan; Yanlei Zhu; Shulin Ren; Chenghai Zhang; Maoxing Liu; Jiafu Ji; Xiangqian Su
Journal:  Surg Endosc       Date:  2018-11-01       Impact factor: 4.584

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.